User profiles for Xavier Calvet

Xavier Calvet

Corporació Sanitària Universitària Parc Taulí. Universitat Autònoma de Barcelona
Verified email at tauli.cat
Cited by 25911

Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis

J Bruix, X Calvet, J Costa, M Ventura, M Bruguera… - The Lancet, 1989 - Elsevier
The prevalence of antibodies against hepatitis C virus (HCV) was investigated in 96 patients
with hepatocellular carcinoma, 106 patients with liver cirrhosis without evidence of cancer, …

Time trends and impact of upper and lower gastrointestinal bleeding and perforation in clinical practice

…, M Castro, M Muñoz, L Rodrigo, X Calvet… - Official journal of the …, 2009 - journals.lww.com
OBJECTIVES: Changing patterns in medical practice may contribute to temporal changes in
the incidence of upper and lower gastrointestinal (GI) complications. There are limited data …

Management of nonvariceal upper gastrointestinal bleeding: guideline recommendations from the International Consensus Group

…, GI Leontiadis, NS Abraham, X Calvet… - Annals of internal …, 2019 - acpjournals.org
Description: This update of the 2010 International Consensus Recommendations on the
Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding (UGIB) refines …

Addition of a second endoscopic treatment following epinephrine injection improves outcome in high-risk bleeding ulcers

X Calvet, M Vergara, E Brullet, JP Gisbert, R Campo - Gastroenterology, 2004 - Elsevier
Background & Aims : Endoscopic therapy reduces the rebleeding rate, the need for surgery,
and the mortality in patients with peptic ulcer and active bleeding or visible vessel. Injection …

Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants

…, Y Arguedas, S García, L Bujanda, X Calvet… - Clinical …, 2015 - Elsevier
Background & Aims Treatment with nonsteroidal anti-inflammatory drugs (NSAIDs) or low-dose
aspirin is associated with increased risk of upper gastrointestinal bleeding. There is little …

Optimum duration of regimens for Helicobacter pylori eradication

…, GI Leontiadis, F Tse, X Calvet… - Cochrane Database …, 2013 - cochranelibrary.com
Background The optimal duration for Helicobacter pylori (H. pylori) eradication therapy is
controversial, with recommendations ranging from 7 to 14 days. Several systematic reviews …

Epinephrine injection versus epinephrine injection and a second endoscopic method in high‐risk bleeding ulcers

M Vergara, X Calvet, JP Gisbert - Cochrane Database of …, 2014 - cochranelibrary.com
Background Endoscopic therapy reduces the rebleeding rate and the need for surgery in
patients with bleeding peptic ulcers. Objectives To determine whether a second procedure …

Sequential therapy for Helicobacter pylori eradication: a critical review

JP Gisbert, X Calvet, A O'Connor… - Journal of clinical …, 2010 - journals.lww.com
… Gisbert JP, Calvet X, Gomollon F, et al. [Eradication treatment of Helicobacter pylori.
Recommendations of the II Spanish Consensus Conference]. … Calvet X, Garcia N, Lopez T …

Diagnosis and Epidemiology of Helicobacter pylori Infection

X Calvet, MJ Ramírez Lázaro, P Lehours… - …, 2013 - Wiley Online Library
A limited amount of new information was published in the field of diagnosis and epidemiology
of H elicobacter pylori this last year. Besides some improvement in current tests, it is …

Prevalence of malnutrition and nutritional characteristics of patients with inflammatory bowel disease

…, MB Gómez-Sánchez, X Calvet… - Journal of Crohn's …, 2017 - academic.oup.com
Background and Aims This study sought to determine the prevalence of malnutrition in patients
with inflammatory bowel disease, to analyse the dietary beliefs and behaviours of these …